About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals takes an iron fist to gastrointestinal ailments and other medical conditions. The company develops internally discovered gastrointestinal drugs. Its lead candidate Linzess (or linaclotide), a treatment for irritable bowel syndrome (IBS) and chronic constipation, was approved by the FDA in 2012. The product was developed with – more... 

Reviews

Overall

5.0
Based on 1 review
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
Compensation/Benefits
Job Security/Advancement
Management
Culture
Claim this company page
Headquarters
301 Binney St.
Cambridge MA, United States 02142
Revenue
$100M to $500M (USD)
Employees
201 to 500
Industry
Links
Ironwood Pharmaceuticals website